GOLDSMITH MARK A bought RVMD
November 25, 2025 · Form 4 insider transaction
GOLDSMITH MARK A bought 60,000 shares of Revolution Medicines, Inc. at $4.09 per share, a transaction worth $245.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$4.09
Total value
$245.4K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 25, 2025
Filing dateNovember 26, 2025
Shares owned after307,863
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Includes 193,475 restricted stock units.